Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating UCN-01 in combination with Topotecan for recurrent, persistent, or progressive advanced ovarian epitheli…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA) [Phase 2]
Phase 2 study evaluating bevacizumab in combination with Doxil for platinum-resistant/refractory ovarian cancer has completed; results were …
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
A completed clinical trial evaluated granulocyte-colony stimulating factor (G-CSF) for prevention of chemotherapy-induced febrile neutropeni…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors [Phase 2]
A Phase 2 trial evaluating consolidation therapy with bevacizumab (Avastin) with or without erlotinib after induction chemotherapy in advanc…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer [NA]
A completed clinical trial evaluating whole-body diffusion MRI for staging, predicting response, and detecting recurrence in ovarian cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian [Phase 1]
Phase 1 trial update of neoadjuvant chemotherapy with weekly paclitaxel, carboplatin, and bevacizumab for ovarian and related cancers; study…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the effect of HER2 activation on Pertuzumab in subjects with advanced ovarian cancer; the study has completed and r…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy [Phase 2]
A Phase 2 trial evaluating maintenance antiangiogenic therapy for ovarian cancer in remission was terminated.
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
The document describes an ongoing clinical trial investigating whether DNA single nucleotide polymorphisms can predict treatment toxicity in…
-
CLINICAL_TRIALS withdrawal · 2015-06-18Clinical Trial Update: Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
A 27-year population-based study analyzes trends in incidence and survival for ovarian germ cell tumors. The associated clinical trial NCT00…
-
CLINICAL_TRIALS withdrawal · 2015-06-18Clinical Trial Update: Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass
A clinical trial evaluating the prediction of ovarian malignancy in the presence of a sonographic pelvic mass has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Phase 2]
Phase 2 trial update of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, primary peritoneal, or related cancers; st…
-
CLINICAL_TRIALS withdrawal · 2015-06-11Clinical Trial Update: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of Tai-chi / Qi-gong for gynecologic cancers has been withdrawn; the study targeted ovarian cancer and primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating rhuMab 2C4 with gemcitabine in ovarian, primary peritoneal, and fallopian tube cancers has completed enr…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of veliparib plus topotecan in relapsed ovarian cancer patients with negat…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Strength Training Study for Survivors of Breast and Gynecologic Cancer [NA]
A completed clinical trial update on a strength training program for survivors of breast cancer and gynecologic cancers, sponsored by the No…
-
FDA approval · 2015-06-02FDA Approved: HYCAMTIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for HYCAMTIN (topotecan hydrochloride) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Research Study in Patients With Advanced Ovarian Epithelial Cancer
A Gynecologic Oncology Group trial in advanced ovarian epithelial cancer was withdrawn.
-
CLINICAL_TRIALS research · 2015-05-29Clinical Trial Update: Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer [NA]
This Clinical Trials update describes an ongoing University College London study testing a stepped approach to improving sexual function aft…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting [Phase 4]
Phase 4 trial comparing fosaprepitant (IV) to aprepitant for prevention of chemotherapy-induced nausea and vomiting; results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats [Phase 2]
Open-label Phase 2 trial assessing efficacy and safety of olaparib in patients with BRCA1/BRCA2 mutations across ovarian, breast, prostate, …
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer [Phase 1]
Phase 1 trial evaluating veliparib with carboplatin and paclitaxel in adults with advanced solid tumors has completed. The study included BR…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for pazopanib/doxorubicin in relapsed platinum-sensitive or resistant ovarian, fallopian tube, or primary peritoneal a…
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer [Phase 2]
A Phase 2, single-arm clinical trial evaluating the combination of everolimus and letrozole for platinum-resistant or persistent ovarian and…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers [Phase 2]
Phase 2 trial evaluating weekly topotecan with bevacizumab in platinum-resistant/recurrent gynecologic cancers; the study (including ovarian…